Effect of glucocorticoids on neuronal and vascular pathology in a transgenic model of selective Müller cell ablation

GLIA

Volumn 62, Issue 7, 2014, Pages 1110-1124

  Shen, Weiyong ^a   Lee, So Ra ^a   Araujo, Joana ^a,b   Chung, Sook H ^a   Zhu, Ling ^a   Gillies, Mark C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Blood retinal barrier; Glucocorticoids; Microglia; M ller cell; Neuroprotection; Photoreceptor; Retina

Indexed keywords

BALANCED SALT SOLUTION; DNA NUCLEOTIDYLEXOTRANSFERASE; GLIAL FIBRILLARY ACIDIC PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTROPHIN 3; NEUROTROPHIN RECEPTOR P75; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN P53; TAMOXIFEN; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A; VASCULOTROPIN INHIBITOR; GLUCOCORTICOID; NERVE GROWTH FACTOR RECEPTOR; NEUROPROTECTIVE AGENT; STRESS ACTIVATED PROTEIN KINASE 1; TNFRSF16 PROTEIN, MOUSE; VASCULAR ENDOTHELIAL GROWTH FACTOR A, MOUSE;

ABLATION THERAPY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL LOSS; CELL PROTECTION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG EFFECT; FLUORESCENCE ANGIOGRAPHY; GLIOSIS; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MACULAR TELANGIECTASIS TYPE 2; MOUSE; MUELLER CELL; MUELLER CELL ABLATION; NEUROTOXICITY; NICK END LABELING; NONHUMAN; PHOTORECEPTOR; PHOTORECEPTOR OUTER SEGMENT; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA DEGENERATION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; RETINA NEOVASCULARIZATION; RETINAL TELANGIECTASIA; SIGNAL TRANSDUCTION; THERAPY EFFECT; TRANSGENIC MOUSE; TRANSGENIC ORGANISM; UPREGULATION; VASCULAR LEAK; VASCULAR LESION; WESTERN BLOTTING; ANIMAL; CELL DEATH; DRUG EFFECTS; MACROGLIA; METABOLISM; MICROGLIA; NEURODEGENERATIVE DISEASES; PATHOLOGY; PATHOPHYSIOLOGY; PHOTORECEPTOR CELL; PHYSIOLOGY; RETINA BLOOD VESSEL; RETINAL DISEASES;

ANIMALS; CELL DEATH; EPENDYMOGLIAL CELLS; GLIOSIS; GLUCOCORTICOIDS; MAP KINASE SIGNALING SYSTEM; MICE, TRANSGENIC; MICROGLIA; MITOGEN-ACTIVATED PROTEIN KINASE 8; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; NEUROTROPHIN 3; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOTORECEPTOR CELLS, VERTEBRATE; RECEPTORS, NERVE GROWTH FACTOR; RETINAL DISEASES; RETINAL VESSELS; TAMOXIFEN; TRIAMCINOLONE ACETONIDE; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEIN P53; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84900543710     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22666     Document Type: Article

References (69)

1. Agarwal N, Agarwal R, Kumar DM, Ondricek A, Clark AF, Wordinger RJ, Pang IH. 2007. Comparison of expression profile of neurotrophins and their receptors in primary and transformed rat retinal ganglion cells. Mol Vis 13:1311-1318.
2. Ambati J, Fowler BJ. 2012. Mechanisms of age-related macular degeneration. Neuron 75:26-39.
3. Arevalo JF, Fromow-Guerra J, Quiroz-Mercado H, Sanchez JG, Wu L, Maia M, Berrocal MH, Solis-Vivanco A, Farah ME. 2007. Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: Results from the Pan-American Collaborative Retina Study Group at 6-month follow-up. Ophthalmology 114:743-750.
4. Arima Y, Nitta M, Kuninaka S, Zhang D, Fujiwara T, Taya Y, Nakao M, Saya H. 2005. Transcriptional blockade induces p53-dependent apoptosis associated with translocation of p53 to mitochondria. J Biol Chem 280:19166-19176.
5. Bai Y, Dergham P, Nedev H, Xu J, Galan A, Rivera JC, ZhiHua S, Mehta HM, Woo SB, Sarunic MV, Neet KE, Saragovi HU. 2010. Chronic and acute models of retinal neurodegeneration TrkA activity are neuroprotective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J Biol Chem 285:39392-39400.
6. Baker BJ, Park KW, Qin H, Ma X, Benveniste EN. 2010. IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 58:1082-1093.
7. Bessis A, Bechade C, Bernard D, Roumier A. 2007. Microglial control of neuronal death and synaptic properties. Glia 55:233-238.
8. Brar VS, Sharma RK, Murthy RK, Chalam KV. 2010. Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells. Mol Vis 16:1848-1853.
9. Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN, Osborne NN, Reichenbach A. 2006. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 25:397-424.
10. Brooks HL Jr, Caballero S Jr, Newell CK, Steinmetz RL, Watson D, Segal MS, Harrison JK, Scott EW, Grant MB. 2004. Vitreous levels of vascular endothelial growth factor and stromal-derived factor 1 in patients with diabetic retinopathy and cystoid macular edema before and after intraocular injection of triamcinolone. Arch Ophthalmol 122:1801-1807.
11. Chipuk JE, Green DR. 2006. Dissecting p53-dependent apoptosis. Cell Death Differ 13:994-1002.
12. Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M, Green DR. 2004. Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science 303:1010-1014.
13. Coorey NJ, Shen W, Chung SH, Zhu L, Gillies MC. 2012. The role of glia in retinal vascular disease. Clin Exp Optom 95:266-281.
14. Donauer J, Schreck I, Liebel U, Weiss C. 2012. Role and interaction of p53, BAX and the stress-activated protein kinases p38 and JNK in benzo(a)pyrene-diolepoxide induced apoptosis in human colon carcinoma cells. Arch Toxicol 86:329-337.
15. Dyer D, Callanan D, Bochow T, Abraham P, Lambert HM, Lee SY, Schneiderman T, Potts SL, Walker TM. 2009. Clinical evaluation of the safety and efficacy of preservative-free triamcinolone (triesence [triamcinolone acetonide injectable suspension] 40 mg/ml) for visualization during pars plana vitrectomy. Retina 29:38-45.
16. Edelman JL. 2010. Differentiating intraocular glucocorticoids. Ophthalmologica 224 Suppl 1:25-30.
17. Ferris FL III, Patz A. 1984. Macular edema. A complication of diabetic retinopathy. Surv Ophthalmol 28 Suppl:452-461.
18. Fischer AJ, Scott MA, Tuten W. 2009. Mitogen-activated protein kinase-signaling stimulates Muller glia to proliferate in acutely damaged chicken retina. Glia 57:166-181.
19. Friedman WJ. 2010. Proneurotrophins, seizures, and neuronal apoptosis. Neuroscientist 16:244-252.
20. Gao H, Qiao X, Gao R, Mieler WF, McPherson AR, Holz ER. 2004. Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina. Vis Res 44:349-356.
21. Gillies MC, Simpson JM, Gaston C, Hunt G, Ali H, Zhu M, Sutter F. 2009. Five-year results of a randomized trial with open-label extension of triamcinolone acetonide for refractory diabetic macular edema. Ophthalmology 116:2182-2187.
22. Gillies MC, Sutter FK, Simpson JM, Larsson J, Ali H, Zhu M. 2006. Intravitreal triamcinolone for refractory diabetic macular edema: Two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113:1533-1538.
23. Glybina IV, Kennedy A, Ashton P, Abrams GW, Iezzi R. 2009. Photoreceptor neuroprotection in RCS rats via low-dose intravitreal sustained-delivery of fluocinolone acetonide. Invest Ophthalmol Vis Sci 50:4847-4857.
24. Gomez-Santos C, Ferrer I, Santidrian AF, Barrachina M, Gil J, Ambrosio S. 2003. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. J Neurosci Res 73:341-350.
25. Harada T, Harada C, Kohsaka S, Wada E, Yoshida K, Ohno S, Mamada H, Tanaka K, Parada LF, Wada K. 2002. Microglia-Muller glia cell interactions control neurotrophic factor production during light-induced retinal degeneration. J Neurosci 22:9228-9236.
26. Harada T, Harada C, Nakayama N, Okuyama S, Yoshida K, Kohsaka S, Matsuda H, Wada K. 2000. Modification of glial-neuronal cell interactions prevents photoreceptor apoptosis during light-induced retinal degeneration. Neuron 26:533-541.
27. Hsu H, Xiong J, Goeddel DV. 1995. The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81:495-504.
28. Ibanez CF, Simi A. 2012. p75 neurotrophin receptor signaling in nervous system injury and degeneration: Paradox and opportunity. Trends Neurosci 35:431-440.
29. Issa PC, Gillies MC, Chew EY, Bird AC, Heeren TF, Peto T, Holz FG, Scholl HP. 2013. Macular telangiectasia type 2. Prog Retin Eye Res 34:49-77.
30. Itakura H, Akiyama H, Hagimura N, Doi H, Tanaka T, Kishi S, Kurabayashi M. 2006. Triamcinolone acetonide suppresses interleukin-1 beta-mediated increase in vascular endothelial growth factor expression in cultured rat Muller cells. Graefes Arch Clin Exp Ophthalmol 244:226-231.
31. Iwama S, Sugimura Y, Suzuki H, Murase T, Ozaki N, Nagasaki H, Arima H, Murata Y, Sawada M, Oiso Y. 2011. Time-dependent changes in proinflammatory and neurotrophic responses of microglia and astrocytes in a rat model of osmotic demyelination syndrome. Glia 59:452-462.
32. Jansen P, Giehl K, Nyengaard JR, Teng K, Lioubinski O, Sjoegaard SS, Breiderhoff T, Gotthardt M, Lin F, Eilers A, Petersen CM, Lewin GR, Hempstead BL, Willnow TE, Nykjaer A. 2007. Roles for the pro-neurotrophin receptor sortilin in neuronal development, aging and brain injury. Nat Neurosci 10:1449-1457.
33. Jebelli JD, Hooper C, Garden GA, Pocock JM. 2012. Emerging roles of p53 in glial cell function in health and disease. Glia 60:515-525.
34. Karunakaran S, Saeed U, Mishra M, Valli RK, Joshi SD, Meka DP, Seth P, Ravindranath V. 2008. Selective activation of p38 mitogen-activated protein kinase in dopaminergic neurons of substantia nigra leads to nuclear translocation of p53 in 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine-treated mice. J Neurosci 28:12500-12509.
35. Kaur C, Rathnasamy G, Ling EA. 2013. Roles of activated microglia in hypoxia induced neuroinflammation in the developing brain and the retina. J Neuroimmune Pharmacol 8:66-78.
36. Kurihara T, Westenskow PD, Bravo S, Aguilar E, Friedlander M. 2012. Targeted deletion of Vegfa in adult mice induces vision loss. J Clin Invest 122:4213-4217.
37. Lebrun-Julien F, Bertrand MJ, De Backer O, Stellwagen D, Morales CR, Di Polo A, Barker PA. 2010. ProNGF induces TNFalpha-dependent death of retinal ganglion cells through a p75NTR non-cell-autonomous signaling pathway. Proc Natl Acad Sci USA 107:3817-3822.
38. Lebrun-Julien F, Morquette B, Douillette A, Saragovi HU, Di Polo A. 2009. Inhibition of p75(NTR) in glia potentiates TrkA-mediated survival of injured retinal ganglion cells. Mol Cell Neurosci 40:410-420.
39. Lee JY, Kim YJ, Kim TY, Koh JY, Kim YH. 2008. Essential role for zinc-triggered p75NTR activation in preconditioning neuroprotection. J Neurosci 28:10919-10927.
40. Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. 2004. Tumor necrosis factor (TNF)-mediated neuroprotection against glutamate-induced excitotoxicity is enhanced by N-methyl-D-aspartate receptor activation. Essential role of a TNF receptor 2-mediated phosphatidylinositol 3-kinase-dependent NF-kappa B pathway. J Biol Chem 279:32869-32881.
41. Moshfeghi AA, Nugent AK, Nomoto H, Sanislo SR, Kitchens JW, Moshfeghi DM. 2009. Triamcinolone acetonide preparations: impact of crystal size on in vitro behavior. Retina 29:689-698.
42. Murakami T, Nishijima K, Akagi T, Uji A, Horii T, Ueda-Arakawa N, Muraoka Y, Yoshimura N. 2012. Optical coherence tomographic reflectivity of photoreceptors beneath cystoid spaces in diabetic macular edema. Invest Ophthalmol Vis Sci 53:1506-1511.
43. Oh CK, Han BS, Choi WS, Youdim MB, Oh YJ. 2011. Translocation and oligomerization of Bax is regulated independently by activation of p38 MAPK and caspase-2 during MN9D dopaminergic neurodegeneration. Apoptosis 16:1087-1100.
44. Ooto S, Hangai M, Takayama K, Arakawa N, Tsujikawa A, Koizumi H, Oshima S, Yoshimura N. 2011. High-resolution photoreceptor imaging in idiopathic macular telangiectasia type 2 using adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci 52:5541-5550.
45. Reichenbach A, Bringmann A. 2013. New functions of Muller cells. Glia 61:651-678.
46. Reichenbach A, Wurm A, Pannicke T, Iandiev I, Wiedemann P, Bringmann A. 2007. Muller cells as players in retinal degeneration and edema. Graefes Arch Clin Exp Ophthalmol 245:627-636.
47. Rivera JC, Sitaras N, Noueihed B, Hamel D, Madaan A, Zhou T, Honore JC, Quiniou C, Joyal JS, Hardy P, Sennlaub F, Lubell W, Chemtob S. 2013. Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A. Arterioscler Thromb Vasc Biol 33:1881-1891.
48. Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B. 2011. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology 118:523-530.
49. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA. 2009. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 106:18751-18756.
50. Saint-Geniez M, Maharaj AS, Walshe TE, Tucker BA, Sekiyama E, Kurihara T, Darland DC, Young MJ, D'Amore PA. 2008. Endogenous VEGF is required for visual function: Evidence for a survival role on muller cells and photoreceptors. PLoS One 3:e3554.
51. Schwartz M, Shechter R. 2010. Systemic inflammatory cells fight off neurodegenerative disease. Nat Rev Neurol 6:405-410.
52. Sears JE, Hoppe G. 2005. Triamcinolone acetonide destabilizes VEGF mRNA in Muller cells under continuous cobalt stimulation. Invest Ophthalmol Vis Sci 46:4336-4341.
53. Shen W, Fruttiger M, Zhu L, Chung SH, Barnett NL, Kirk JK, Lee S, Coorey NJ, Killingsworth M, Sherman LS, Gillies MC. 2012. Conditional Mullercell ablation causes independent neuronal and vascular pathologies in a novel transgenic model. J Neurosci 32:15715-15727.
54. Shen W, Zhu L, Lee SR, Chung SH, Gillies MC. 2013. Involvement of NT3 and P75NTR in photoreceptor degeneration following selective Muller cell ablation. J Neuroinflammation 10:137.
55. Silva PS, Sun JK, Aiello LP. 2009. Role of steroids in the management of diabetic macular edema and proliferative diabetic retinopathy. Semin Ophthalmol 24:93-99.
56. Srinivasan B, Roque CH, Hempstead BL, Al-Ubaidi MR, Roque RS. 2004. Microglia-derived pronerve growth factor promotes photoreceptor cell death via p75 neurotrophin receptor. J Biol Chem 279:41839-41845.
57. Tao J, Wu H, Lin Q, Wei W, Lu XH, Cantle JP, Ao Y, Olsen RW, Yang XW, Mody I, Sofroniew MV, Sun YE. 2011. Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration. J Neurosci 31:8306-8319.
58. Tauris J, Gustafsen C, Christensen EI, Jansen P, Nykjaer A, Nyengaard JR, Teng KK, Schwarz E, Ovesen T, Madsen P, Petersen CM. 2011. Proneurotrophin-3 may induce Sortilin-dependent death in inner ear neurons. Eur J Neurosci 33:622-631.
59. Taylor S, Srinivasan B, Wordinger RJ, Roque RS. 2003. Glutamate stimulates neurotrophin expression in cultured Muller cells. Brain Res Mol Brain Res 111:189-197.
60. Vuong L, Conley SM, Al-Ubaidi MR. 2012. Expression and role of p53 in the retina. Invest Ophthalmol Vis Sci 53:1362-1371.
61. Wake H, Moorhouse AJ, Jinno S, Kohsaka S, Nabekura J. 2009. Resting microglia directly monitor the functional state of synapses in vivo and determine the fate of ischemic terminals. J Neurosci 29:3974-3980.
62. Walton NM, Sutter BM, Laywell ED, Levkoff LH, Kearns SM, Marshall GP II, Scheffler B, Steindler DA. 2006. Microglia instruct subventricular zone neurogenesis. Glia 54:815-825.
63. Wang LL, Chen H, Huang K, Zheng L. 2012. Elevated histone acetylations in Muller cells contribute to inflammation: a novel inhibitory effect of minocycline. Glia 60:1896-1905.
64. Weidemann A, Krohne TU, Aguilar E, Kurihara T, Takeda N, Dorrell MI, Simon MC, Haase VH, Friedlander M, Johnson RS. 2010. Astrocyte hypoxic response is essential for pathological but not developmental angiogenesis of the retina. Glia 58:1177-1185.
65. Wenzel A, Grimm C, Seeliger MW, Jaissle G, Hafezi F, Kretschmer R, Zrenner E, Reme CE. 2001. Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor. Invest Ophthalmol Vis Sci 42:1653-1659.
66. Whitmire W, Al-Gayyar MM, Abdelsaid M, Yousufzai BK, El-Remessy AB. 2011. Alteration of growth factors and neuronal death in diabetic retinopathy: What we have learned so far. Mol Vis 17:300-308.
67. Yohannan J, Bittencourt M, Sepah YJ, Hatef E, Sophie R, Moradi A, Liu H, Ibrahim M, Do DV, Coulantuoni E, Nguyen QD. 2013. Association of retinal sensitivity to integrity of photoreceptor inner/outer segment junction in patients with diabetic macular edema. Ophthalmology 120:1254-1261.
68. Yoshida N, Ikeda Y, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Enaida H, Ishibashi T. 2013. Laboratory evidence of sustained chronic inflammatory reaction in retinitis pigmentosa. Ophthalmology 120:e5-12.
69. Zhang X, Lai D, Bao S, Hambly BD, Gillies MC. 2013. Triamcinolone acetonide inhibits p38MAPK activation and neuronal apoptosis in early diabetic retinopathy. Curr Mol Med 13:946-958.